Biostage, Inc. (19)
Browse by Contract Category
Contracts
-
Form of Securities Purchase Agreement, dated as of September 1, 2021
(Filed With SEC on September 8, 2021)
-
Consulting Agreement, executed October 6, 2020, between Biostage, Inc. and Danforth Advisors, LLC
(Filed With SEC on October 30, 2020)
-
Description of Securities
(Filed With SEC on March 27, 2020)
-
Form of Warrant
(Filed With SEC on September 8, 2021)
-
Form of Securities Purchase Agreement, dated as of June 17, 2021
(Filed With SEC on June 22, 2021)
-
Form of Warrant
(Filed With SEC on June 22, 2021)
-
Securities Purchase Agreement by and between Biostage, Inc. and Dao Capital Group Limited, dated August 20, 2020
(Filed With SEC on August 20, 2020)
-
Securities Purchase Agreement by and between Biostage, Inc. and Dao Capital Group Limited, dated August 18, 2020
(Filed With SEC on August 20, 2020)
-
Promissory Note, dated as of May 1, 2020, by Biostage, Inc. in favor of Bank of America, NA
(Filed With SEC on May 5, 2020)
-
Offer Letter by and between Biostage, Inc. and Peter Chakoutis, dated as of March 24, 2020
(Filed With SEC on March 24, 2020)
-
Separation and Release Agreement by and between Biostage, Inc. and James McGorry
(Filed With SEC on February 7, 2020)
-
Securities Purchase Agreement dated as of December 31, 2019
(Filed With SEC on January 2, 2020)
-
Form of Common Stock Purchase Warrant
(Filed With SEC on January 2, 2020)
-
Form of Amendment to Common Stock Purchase Warrant
(Filed With SEC on December 18, 2019)
-
Separation and Release Agreement by and between Biostage, Inc. and Thomas McNaughton
(Filed With SEC on June 17, 2019)
-
Securities Purchase Agreement between the Company and Junli He, dated as of June 12, 2019
(Filed With SEC on June 17, 2019)
-
Form of Warrant
(Filed With SEC on June 17, 2019)
-
Director Compensation Arrangements
(Filed With SEC on March 29, 2019)
-
2013 Equity Incentive Plan, as amended
(Filed With SEC on March 29, 2019)
